These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 15029481)
1. Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Djoussé L; Knowlton B; Hayden MR; Almqvist EW; Brinkman RR; Ross CA; Margolis RL; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo Cabrero D; Jones R; Zanko A; Nance M; Abramson RK; Suchowersky O; Paulsen JS; Harrison MB; Yang Q; Cupples LA; Mysore J; Gusella JF; MacDonald ME; Myers RH Neurogenetics; 2004 Jun; 5(2):109-14. PubMed ID: 15029481 [TBL] [Abstract][Full Text] [Related]
2. Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Djoussé L; Knowlton B; Hayden M; Almqvist EW; Brinkman R; Ross C; Margolis R; Rosenblatt A; Durr A; Dode C; Morrison PJ; Novelletto A; Frontali M; Trent RJ; McCusker E; Gómez-Tortosa E; Mayo D; Jones R; Zanko A; Nance M; Abramson R; Suchowersky O; Paulsen J; Harrison M; Yang Q; Cupples LA; Gusella JF; MacDonald ME; Myers RH Am J Med Genet A; 2003 Jun; 119A(3):279-82. PubMed ID: 12784292 [TBL] [Abstract][Full Text] [Related]
3. Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene. Valcárcel-Ocete L; Alkorta-Aranburu G; Iriondo M; Fullaondo A; García-Barcina M; Fernández-García JM; Lezcano-García E; Losada-Domingo JM; Ruiz-Ojeda J; Álvarez de Arcaya A; Pérez-Ramos JM; Roos RA; Nielsen JE; Saft C; ; Zubiaga AM; Aguirre A PLoS One; 2015; 10(7):e0131573. PubMed ID: 26148071 [TBL] [Abstract][Full Text] [Related]
4. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Li JL; Hayden MR; Almqvist EW; Brinkman RR; Durr A; Dodé C; Morrison PJ; Suchowersky O; Ross CA; Margolis RL; Rosenblatt A; Gómez-Tortosa E; Cabrero DM; Novelletto A; Frontali M; Nance M; Trent RJ; McCusker E; Jones R; Paulsen JS; Harrison M; Zanko A; Abramson RK; Russ AL; Knowlton B; Djoussé L; Mysore JS; Tariot S; Gusella MF; Wheeler VC; Atwood LD; Cupples LA; Saint-Hilaire M; Cha JH; Hersch SM; Koroshetz WJ; Gusella JF; MacDonald ME; Myers RH Am J Hum Genet; 2003 Sep; 73(3):682-7. PubMed ID: 12900792 [TBL] [Abstract][Full Text] [Related]
5. [Molecular genetics of Huntington's disease]. Goto J; Masuda N; Watanabe M; Kanazawa I Rinsho Shinkeigaku; 1995 Dec; 35(12):1529-31. PubMed ID: 8752453 [TBL] [Abstract][Full Text] [Related]
6. Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Lee JM; Gillis T; Mysore JS; Ramos EM; Myers RH; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Squitieri F; Griguoli A; Di Donato S; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Abramson RK; Marder K; Sequeiros J; MacDonald ME; Gusella JF Am J Hum Genet; 2012 Mar; 90(3):434-44. PubMed ID: 22387017 [TBL] [Abstract][Full Text] [Related]
7. 4p16.3 haplotype modifying age at onset of Huntington disease. Nørremølle A; Budtz-Jørgensen E; Fenger K; Nielsen JE; Sørensen SA; Hasholt L Clin Genet; 2009 Mar; 75(3):244-50. PubMed ID: 19250382 [TBL] [Abstract][Full Text] [Related]
8. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease. Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024 [TBL] [Abstract][Full Text] [Related]
9. ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease. Arning L; Monté D; Hansen W; Wieczorek S; Jagiello P; Akkad DA; Andrich J; Kraus PH; Saft C; Epplen JT J Mol Med (Berl); 2008 Apr; 86(4):485-90. PubMed ID: 18327563 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. Li JL; Hayden MR; Warby SC; Durr A; Morrison PJ; Nance M; Ross CA; Margolis RL; Rosenblatt A; Squitieri F; Frati L; Gómez-Tortosa E; García CA; Suchowersky O; Klimek ML; Trent RJ; McCusker E; Novelletto A; Frontali M; Paulsen JS; Jones R; Ashizawa T; Lazzarini A; Wheeler VC; Prakash R; Xu G; Djoussé L; Mysore JS; Gillis T; Hakky M; Cupples LA; Saint-Hilaire MH; Cha JH; Hersch SM; Penney JB; Harrison MB; Perlman SL; Zanko A; Abramson RK; Lechich AJ; Duckett A; Marder K; Conneally PM; Gusella JF; MacDonald ME; Myers RH BMC Med Genet; 2006 Aug; 7():71. PubMed ID: 16914060 [TBL] [Abstract][Full Text] [Related]
11. Population stratification may bias analysis of PGC-1α as a modifier of age at Huntington disease motor onset. Ramos EM; Latourelle JC; Lee JH; Gillis T; Mysore JS; Squitieri F; Di Pardo A; Di Donato S; Hayden MR; Morrison PJ; Nance M; Ross CA; Margolis RL; Gomez-Tortosa E; Ayuso C; Suchowersky O; Trent RJ; McCusker E; Novelletto A; Frontali M; Jones R; Ashizawa T; Frank S; Saint-Hilaire MH; Hersch SM; Rosas HD; Lucente D; Harrison MB; Zanko A; Marder K; Gusella JF; Lee JM; Alonso I; Sequeiros J; Myers RH; Macdonald ME Hum Genet; 2012 Dec; 131(12):1833-40. PubMed ID: 22825315 [TBL] [Abstract][Full Text] [Related]
12. A Huntington disease-like neurodegenerative disorder maps to chromosome 20p. Xiang F; Almqvist EW; Huq M; Lundin A; Hayden MR; Edström L; Anvret M; Zhang Z Am J Hum Genet; 1998 Nov; 63(5):1431-8. PubMed ID: 9792871 [TBL] [Abstract][Full Text] [Related]
13. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length. Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007 [TBL] [Abstract][Full Text] [Related]
14. NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Arning L; Kraus PH; Valentin S; Saft C; Andrich J; Epplen JT Neurogenetics; 2005 Feb; 6(1):25-8. PubMed ID: 15742215 [TBL] [Abstract][Full Text] [Related]
15. Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase. Long JD; Lee JM; Aylward EH; Gillis T; Mysore JS; Abu Elneel K; Chao MJ; Paulsen JS; MacDonald ME; Gusella JF Am J Hum Genet; 2018 Sep; 103(3):349-357. PubMed ID: 30122542 [TBL] [Abstract][Full Text] [Related]
16. Late-onset Huntington disease with intermediate CAG repeats: true or false? Groen JL; de Bie RM; Foncke EM; Roos RA; Leenders KL; Tijssen MA J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):228-30. PubMed ID: 20145031 [TBL] [Abstract][Full Text] [Related]
17. Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes. Chattopadhyay B; Baksi K; Mukhopadhyay S; Bhattacharyya NP Neurosci Lett; 2005 Feb; 374(2):81-6. PubMed ID: 15644269 [TBL] [Abstract][Full Text] [Related]
18. Genetic background of Huntington disease in Croatia: Molecular analysis of CAG, CCG, and Delta2642 (E2642del) polymorphisms. Hećimović S; Klepac N; Vlasić J; Vojta A; Janko D; Skarpa-Prpić I; Canki-Klain N; Marković D; Bozikov J; Relja M; Pavelić K Hum Mutat; 2002 Sep; 20(3):233. PubMed ID: 12204002 [TBL] [Abstract][Full Text] [Related]
19. CNR1 variation is associated with the age at onset in Huntington disease. Kloster E; Saft C; Epplen JT; Arning L Eur J Med Genet; 2013 Aug; 56(8):416-9. PubMed ID: 23747361 [TBL] [Abstract][Full Text] [Related]
20. No association between polymorphisms in the BDNF gene and age at onset in Huntington disease. Mai M; Akkad AD; Wieczorek S; Saft C; Andrich J; Kraus PH; Epplen JT; Arning L BMC Med Genet; 2006 Nov; 7():79. PubMed ID: 17096834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]